Central India Chronicle

Ankylosing Spondylitis Pipeline Assessment, Key Companies, And Emerging Drugs

 Breaking News
  • No posts were found

Ankylosing Spondylitis Pipeline Assessment, Key Companies, And Emerging Drugs

April 28
01:57 2021
Ankylosing Spondylitis Pipeline Assessment, Key Companies, And Emerging Drugs

Delveinsight Business Research LLP

“Ankylosing Spondylitis Pipeline Insight, 2021” report by DelveInsight outlines comprehensive insights of present clinical development scenario and growth prospects across the Ankylosing Spondylitis Market.

The Ankylosing Spondylitis Pipeline report embraces in-depth commercial and clinical assessment of the Ankylosing Spondylitis pipeline products from the pre-clinical developmental phase to the marketed phase. 

The report covers a detailed description of the drug including mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, Ankylosing Spondylitis collaborations, mergers, acquisition, funding, designations, and other product-related details.

Get FREE sample copy at https://www.delveinsight.com/sample-request/ankylosing-spondylitis-bekhterevs-disease-pipeline-insight

Currently, the cure for Ankylosing Spondylitis is not available in the market, and the available therapies mainly help to reduce the discomfort, pain, and inflammation caused by Ankylosing Spondylitis. In terms of molecule type, the market can be segregated into small molecules, biologics, and biosimilars.

Ankylosing Spondylitis Therapies covered in the report include:
Tofacitinib
Bimekizumab
Filgotinib
Tildrakizumab
Upadacitinib
KHK4827
And many more.

As per the DelveInsight, the dynamics of the Ankylosing Spondylitis market is anticipated to change in the coming years owing to the expected launch of emerging therapies during the forecasted period.

Ankylosing Spondylitis Pipeline Analysis

Ankylosing Spondylitis Pipeline Analysis

The report provides insights into: 

  • The report provides detailed insights about companies that are developing therapies for the treatment of Ankylosing Spondylitis with aggregate therapies developed by each company for the same.

  • It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late stage of development for the Ankylosing Spondylitis Treatment.

  • Ankylosing Spondylitis key companies involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.

  • Ankylosing Spondylitis Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type. 

  • Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Ankylosing Spondylitis market.

The report is built using data and information traced from the researcher’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.  

Ankylosing Spondylitis Companies:
Pfizer
Merck
Abbvie
Kyowa Kirin
UCB Biopharma
Galapagos NV
Sun Pharmaceuticals
And many others.

Report Highlights

  • A better understanding of disease pathogenesis contributing to the development of novel therapeutics for Ankylosing Spondylitis.    

  • In the coming years, the Ankylosing Spondylitis market is set to change due to the rising awareness of the disease, and incremental healthcare spending across the world; which would expand the size of the market to enable the drug manufacturers to penetrate more into the market. 

  • The companies and academics are working to assess challenges and seek opportunities that could influence Ankylosing Spondylitis Research & Development. The therapies under development are focused on novel approaches to treat/improve the disease condition.

  • A detailed portfolio of major pharma players who are involved in fueling the Ankylosing Spondylitis treatment market. Several potential therapies for Ankylosing Spondylitis are under investigation. With the expected launch of these emerging therapies, it is expected that there will be a significant impact on the Ankylosing Spondylitis market size in the coming years.  

  • Our in-depth analysis of the Ankylosing Spondylitis pipeline assets (in early-stage, mid-stage, and late stage of development) includes therapeutic assessment and comparative analysis. This will support the clients in the decision-making process regarding their therapeutic portfolio by identifying the overall scenario of the research and development activities. 

Table of Content

1. Report Introduction

2. Ankylosing Spondylitis 

3. Ankylosing Spondylitis Current Treatment Patterns

4. Ankylosing Spondylitis – DelveInsight’s Analytical Perspective

5. Therapeutic Assessment

6. Ankylosing Spondylitis Late Stage Products (Phase-III)

7. Ankylosing Spondylitis Mid Stage Products (Phase-II)

8. Early Stage Products (Phase-I)

9. Pre-clinical Products and Discovery Stage Products

10. Inactive Products

11. Dormant Products

12. Ankylosing Spondylitis Discontinued Products

13. Ankylosing Spondylitis Product Profiles

14. Ankylosing Spondylitis Key Companies

15. Ankylosing Spondylitis Key Products

16. Dormant and Discontinued Products

17. Ankylosing Spondylitis Unmet Needs

18. Ankylosing Spondylitis Future Perspectives

19. Ankylosing Spondylitis Analyst Review  

20. Appendix

21. Report Methodology

*The table of contents is not exhaustive; the final content may vary. 

Latest Reports By DelveInsight
Ankylosing Spondylitis Market Insight
DelveInsight’s “Ankylosing Spondylitis Market Insights, Epidemiology, and Market Forecast 2030” report delivers an in-depth understanding of the historical and forecasted epidemiology as well as the Ankylosing Spondylitis market size, share, and trend analysis for the 7MM (i.e the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan).

Sacral Nerve Stimulation Devices Market
DelveInsight’s ‘Sacral Nerve Stimulation Devices Market Insights, Competitive Landscape and Market Forecast – 2025’ report delivers an in-depth understanding of Sacral Nerve Stimulation Devices and the historical and forecasted Sacral Nerve Stimulation Devices market trends in the US, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.

About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: www.delveinsight.com/

Related Articles